港股異動 | 騰訊跌2.75% 南下資金連續八日淨賣出 累計超94億港元
格隆匯11月23日丨騰訊(0700.HK)跌2.75%,報480.8港元,總市值46133億港元。南下資金昨日淨賣出24.13億港元。其中騰訊控股遭淨賣出8.3億港元,南下資金已連續八日淨賣出騰訊,累計94.54億港元。上週末,市場監管總局根據《中華人民共和國反壟斷法》,對四十三起未依法申報違法實施經營者集中案件立案調查。市場監管總局根據《中華人民共和國反壟斷法》第四十八條、四十九條作出行政處罰決定,對涉案企業分別處以50萬元罰款。其中就包括騰訊控股有限公司收購中國醫療在線公司股權案等。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.